News

How cells replicate damaged DNA? Duxin lab revisited lesion bypass

It is not always safe to repair DNA Damage. Sometimes, cells "just bypass it". This review takes a fresh look at how cells replicate damaged DNA. During DNA replication, repair of lesions on DNA can be dangerous. Cells instead "tolerate" DNA damage and focus on finishing replication. This review, by Sidak Minocha, RepliFate members Marta Oliva-Santiago and Julien Duxin, and Sampath Amitash Gadi from the Biotech Research & Innovation Centre (BRIC) at the University of Copenhagen, revisited lesion bypass in light of recent advances.   FULL ARTICLE [...]

February 5, 2026|Publications|

Titia Sixma’s lab showed how USP1/UAF1 targets polyubiquitinated PCNA with an exo-cleavage mechanism

Another recent publication highlight! The lab of Titia Sixma published a new study on how USP1/UAF1 can cleave ubiquitin chains on PCNA through an exo-cleavage mechanism. Key findings: USP1/UAF1 prefers to cleave K63- and K48 on polyubiquitinated PCNA using exo-cleavage. USP1/UAF1 prefers to cleave ubiquitin-ubiquitin bond over PCNA-ubiquitin bond. UAF1 plays a minor role in exo-cleavage preference for K63-PCNA-UbN. - USP1/UAF1 uses a bind, cleave and release mechanism when acting on PCNA-UbN.   FULL ARTICLE

August 5, 2025|Publications|

Collaboration between the labs of Lecona and Méndez uncovered a novel regulatory mechanism in DNA replication involving VPC/p97

The labs of Emilio Lecona Sagrado and Juan Méndez published a new study uncovering a novel regulatory mechanism in DNA replication involving VPC/p97. Their research reveals that VPC/p97-mediated extraction of DNA Pol α/primase from chromatin restricts overactivation of the ATR checkpoint pathway during unperturbed DNA replication. Key findings: VCP/p97 removes Pol α/primase from chromatin to suppress TOPBP1-dependent ATR activation under unperturbed replication conditions. Inhibition of VCP/p97 leads to the accumulation of Pol α/primase on chromatin, enhancing ATR signalling and triggering cell cycle arrest at G2/M. VCP/p97 acts as a safeguard against replication stress overreaction. [...]

July 20, 2025|Publications|

2nd Replifate Meeting in Amsterdam: 18-19 Internal Meeting

The Netherlands Cancer Institute (NKI) in Amsterdam hosted the 2nd Replifate Meeting, "DNA replication at the heart of cell fate decisions and cancer development", on November 20 and 21, 2024.The two-day event followed the network's first annual meeting in Baeza in October 2023. It brought the Replifate consortium together again to share recent advances in DNA replication research and how it shapes cell fate decisions and cancer development, the scientific focus of the project.The meeting was a good space for scientific exchange and networking. It helped strengthen collaborations within the network as the [...]

November 21, 2024|News|

New Study Reveals PARP1’s Critical Role in Repairing DNA-Protein Crosslinks

Researchers from RepliFate have uncovered a novel DNA repair pathway orchestrated by the enzyme PARP1 that targets toxic DNA-protein crosslinks (DPCs). The study, published in Nature Communications, provides new insights into how cells handle these dangerous lesions and may explain the synergistic effects of certain cancer treatments. Key findings: PARP1 senses DPCs on single-stranded DNA gaps and those flanked by DNA nicks, like topoisomerase 1 cleavage complexes (TOP1ccs) PARP1 directly modifies the crosslinked proteins with poly(ADP-ribose) chains This PARylation triggers ubiquitination and subsequent degradation of the DPCs by the proteasome and other proteases Without [...]

August 14, 2024|Publications|
Go to Top